Experimental shot targets tumors directly in early trial
NCT ID NCT05727839
First seen Mar 30, 2026 · Last updated Apr 30, 2026 · Updated 5 times
Summary
This early-phase study tested an experimental drug called JCXH-211, which is injected directly into tumors. It involved 19 adults with advanced solid cancers that had stopped responding to standard treatments. The main goals were to check safety and find the right dose, while also watching for any tumor shrinkage.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sun Yat-sen University Cancer Center
Guangdong, Guangzhou, 510060, China
-
The George Washington Medical Faculty Associates
Washington D.C., District of Columbia, 20037, United States
Conditions
Explore the condition pages connected to this study.